Key Takeaways

The development of anaplastic large-cell lymphomas is a rare, but established, risk of post-mastectomy implant-based breast reconstruction.

In this study, breast implants after mastectomy were also associated with an increased risk of other non-Hodgkin lymphomas.

The results suggest that continued monitoring of breast implant-associated malignant neoplasms is warranted.

Aside from the established risk of anaplastic large-cell lymphomas (ALCLs), breast implants after mastectomy were also associated with an increased risk of other non-Hodgkin lymphomas (NHLs), according to results from a population-based cohort study.

Among over 61,000 women who underwent post-mastectomy implant-based breast reconstruction, 15 subsequent NHLs of the breast occurred (standardized incidence

See Full Page